Regrettably, we did not observe changes in XOD and ADA enzyme activities after MOS treatment, indicating that MOS may be anti-hyperuricemia not by affecting uric acid synthesis, but by influencing uric acid excretion. Here, ADA is linked to hyperuricemia.